Exact Mass: 578.3458
Exact Mass Matches: 578.3458
Found 500 metabolites which its exact mass value is equals to given mass value 578.3458
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Asparagoside A
Melongoside A is found in fruits. Melongoside A is a constituent of aubergine (Solanum melongena).
Oscillatoxin A
Anhydroamarouciaxanthin B
Anhydroamarouciaxanthin B is found in blue mussel. Anhydroamarouciaxanthin B is a constituent of Mytilus edulis (blue mussel). Constituent of Mytilus edulis (blue mussel). Anhydroamarouciaxanthin B is found in blue mussel and mollusks.
PA(10:0/17:0)
PA(10:0/17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/17:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of margaric acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(8:0/19:0)
PA(8:0/19:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/19:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of nonadecylic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(10:0/a-17:0)
PA(10:0/a-17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/a-17:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of anteisoheptadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(10:0/i-17:0)
PA(10:0/i-17:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/i-17:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of isoheptadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(8:0/i-19:0)
PA(8:0/i-19:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/i-19:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of isononadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(a-13:0/i-14:0)
PA(a-13:0/i-14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/i-14:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of isotetradecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-12:0/a-15:0)
PA(i-12:0/a-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/a-15:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of anteisopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-12:0/i-15:0)
PA(i-12:0/i-15:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/i-15:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of isopentadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-13:0/i-14:0)
PA(i-13:0/i-14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/i-14:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of isotetradecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-14:0/a-13:0)
PA(i-14:0/a-13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-14:0/a-13:0), in particular, consists of one chain of isotetradecanoic acid at the C-1 position and one chain of anteisotridecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-14:0/i-13:0)
PA(i-14:0/i-13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-14:0/i-13:0), in particular, consists of one chain of isotetradecanoic acid at the C-1 position and one chain of isotridecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
Chenodeoxycholyltryptophan
Chenodeoxycholyltryptophan belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Chenodeoxycholyltryptophan consists of the bile acid chenodeoxycholic acid conjugated to the amino acid Tryptophan conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Chenodeoxycholyltryptophan, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Chenodeoxycholyltryptophan appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
Deoxycholyltryptophan
Deoxycholyltryptophan belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Deoxycholyltryptophan consists of the bile acid deoxycholic acid conjugated to the amino acid Tryptophan conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Deoxycholyltryptophan, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Deoxycholyltryptophan appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
DG(10:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0)
DG(10:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/10:0/0:0)
DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(10:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))
DG(10:0/0:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/10:0)
DG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Timosaponin A1
Timosaponin A1 is a natural product found in Anemarrhena asphodeloides with data available. Timosaponin A1 is a coprostane type steroidal saponin isolated from Rhizoma Anemarrhenae. Timosaponin A1 is a coprostane type steroidal saponin isolated from Rhizoma Anemarrhenae.
3alpha-Angeloyloxy-18beta-glucopyranosyloxy-ent-labd-8(17),13-dien-15,16-olide
Macrolactin P
7-hydroxy-23,24-dihydrocucurbitacin F 25-O-acetate|Hemslecin G
(22S)-cholesta-5,24-diene-3beta,11alpha,16beta,22-tetrol 16-O-alpha-L-rhamnopyranoside|(22S)-Cholesta-5,24-diene-3??,11??,16??,22-tetrol 16-O-??-L-rhamnopyranoside
16beta-Acetoxy-14-hydroxy-3beta-alpha-L-rhamnopyranosyloxy-5beta,14beta-card-20(22)-enolid|16beta-acetoxy-14-hydroxy-3beta-alpha-L-rhamnopyranosyloxy-5beta,14beta-card-20(22)-enolide
6alpha-O-beta-D-quinovopyranosyl-(25R)-5alpha-spirostan-3beta-ol|6alpha-O-beta-quinovopyranosyl-(25R)-5alpha-spirostan-3beta-ol|saponin Sc-4|SC-4
cholestane-1beta,3beta,5alpha,6beta-tetraol 1,3,6-triacetate
(7S,8R,8R,4S,5S,7S,10S)-9-O-(11-hydroxyeudesman-4-yl)-dihydrosesamin
16-O-acetyl-hydroxyperiplogenin 3-O-beta-D-digitoxopyranoside
(25S)-3beta-hydroxy-5alpha-spirostan-6alpha-yl-O-beta-D-xylopyranoside
8alpha,9alpha-Epoxide,10beta-hydroxy,25-Me ether-Antibiotic FD 892|FD-891
Tyr Gln Ile Arg
C32H50O9_beta-D-Xylopyranoside, 3,17-dihydroxyspirost-5-en-1-yl
putative tryptophane conjugated chenodeoxycholic acid
putative tryptophane conjugated chenodeoxycholic acid (clustered spectrum)
Ala Phe Arg Trp
Ala Phe Trp Arg
Ala Arg Phe Trp
Ala Arg Trp Phe
Ala Trp Phe Arg
Ala Trp Arg Phe
Glu Phe Lys Arg
Glu Phe Arg Lys
Glu Lys Phe Arg
Glu Lys Arg Phe
Glu Arg Phe Lys
Glu Arg Lys Phe
Phe Ala Arg Trp
Phe Ala Trp Arg
Phe Glu Lys Arg
Phe Glu Arg Lys
Phe Lys Glu Arg
Phe Lys Arg Glu
Phe Lys Val Trp
Phe Lys Trp Val
Phe Arg Ala Trp
Phe Arg Glu Lys
Phe Arg Lys Glu
Phe Arg Arg Thr
Phe Arg Thr Arg
Phe Arg Trp Ala
Phe Thr Arg Arg
Phe Val Lys Trp
Phe Val Trp Lys
Phe Trp Ala Arg
Phe Trp Lys Val
Phe Trp Arg Ala
Phe Trp Val Lys
Ile Lys Arg Tyr
Ile Lys Tyr Arg
Ile Gln Arg Tyr
Ile Gln Tyr Arg
Ile Arg Lys Tyr
Ile Arg Gln Tyr
Ile Arg Tyr Lys
Ile Arg Tyr Gln
Ile Tyr Lys Arg
Ile Tyr Gln Arg
Ile Tyr Arg Lys
Ile Tyr Arg Gln
Lys Glu Phe Arg
Lys Glu Arg Phe
Lys Phe Glu Arg
Lys Phe Arg Glu
Lys Phe Val Trp
Lys Phe Trp Val
Lys Ile Arg Tyr
Lys Ile Tyr Arg
Lys Leu Arg Tyr
Lys Leu Tyr Arg
Lys Arg Glu Phe
Lys Arg Phe Glu
Lys Arg Ile Tyr
Lys Arg Leu Tyr
Lys Arg Tyr Ile
Lys Arg Tyr Leu
Lys Val Phe Trp
Lys Val Trp Phe
Lys Trp Phe Val
Lys Trp Val Phe
Lys Tyr Ile Arg
Lys Tyr Leu Arg
Lys Tyr Arg Ile
Lys Tyr Arg Leu
Leu Lys Arg Tyr
Leu Lys Tyr Arg
Leu Gln Arg Tyr
Leu Gln Tyr Arg
Leu Arg Lys Tyr
Leu Arg Gln Tyr
Leu Arg Tyr Lys
Leu Arg Tyr Gln
Leu Tyr Lys Arg
Leu Tyr Gln Arg
Leu Tyr Arg Lys
Leu Tyr Arg Gln
Gln Ile Arg Tyr
Gln Ile Tyr Arg
Gln Leu Arg Tyr
Gln Leu Tyr Arg
Gln Arg Ile Tyr
Gln Arg Leu Tyr
Gln Arg Tyr Ile
Gln Arg Tyr Leu
Gln Tyr Ile Arg
Gln Tyr Leu Arg
Gln Tyr Arg Ile
Gln Tyr Arg Leu
Arg Ala Phe Trp
Arg Ala Trp Phe
Arg Glu Phe Lys
Arg Glu Lys Phe
Arg Phe Ala Trp
Arg Phe Glu Lys
Arg Phe Lys Glu
Arg Phe Arg Thr
Arg Phe Thr Arg
Arg Phe Trp Ala
Arg Ile Lys Tyr
Arg Ile Gln Tyr
Arg Ile Tyr Lys
Arg Ile Tyr Gln
Arg Lys Glu Phe
Arg Lys Phe Glu
Arg Lys Ile Tyr
Arg Lys Leu Tyr
Arg Lys Tyr Ile
Arg Lys Tyr Leu
Arg Leu Lys Tyr
Arg Leu Gln Tyr
Arg Leu Tyr Lys
Arg Leu Tyr Gln
Arg Gln Ile Tyr
Arg Gln Leu Tyr
Arg Gln Tyr Ile
Arg Gln Tyr Leu
Arg Arg Phe Thr
Arg Arg Thr Phe
Arg Thr Phe Arg
Arg Thr Arg Phe
Arg Trp Ala Phe
Arg Trp Phe Ala
Arg Tyr Ile Lys
Arg Tyr Ile Gln
Arg Tyr Lys Ile
Arg Tyr Lys Leu
Arg Tyr Leu Lys
Arg Tyr Leu Gln
Arg Tyr Gln Ile
Arg Tyr Gln Leu
Thr Phe Arg Arg
Thr Arg Phe Arg
Thr Arg Arg Phe
Val Phe Lys Trp
Val Phe Trp Lys
Val Lys Phe Trp
Val Lys Trp Phe
Val Trp Phe Lys
Val Trp Lys Phe
Trp Phe Lys Val
Trp Phe Val Lys
Trp Lys Phe Val
Trp Lys Val Phe
Trp Val Phe Lys
Trp Val Lys Phe
Tyr Ile Lys Arg
Tyr Ile Gln Arg
Tyr Ile Arg Lys
Tyr Ile Arg Gln
Tyr Lys Ile Arg
Tyr Lys Leu Arg
Tyr Lys Arg Ile
Tyr Lys Arg Leu
Tyr Leu Lys Arg
Tyr Leu Gln Arg
Tyr Leu Arg Lys
Tyr Leu Arg Gln
Tyr Gln Leu Arg
Tyr Gln Arg Ile
Tyr Gln Arg Leu
Tyr Arg Ile Lys
Tyr Arg Ile Gln
Tyr Arg Lys Ile
Tyr Arg Lys Leu
Tyr Arg Leu Lys
Tyr Arg Leu Gln
Tyr Arg Gln Ile
Tyr Arg Gln Leu
1,25-Dihydroxyvitamin D3 3-glycoside
Pandaroside D
Asparagoside A
Isolated from rhizomes of Mexican sarsaparilla (Smilax aristolochiaefolia) and from asparagus (Asparagus officinalis) root. Asparagoside A is found in asparagus, herbs and spices, and green vegetables.
Anhydroamarouciaxanthin B
Cyathsterone A
Cyathsterone B
(25S)-5beta-spirostan-3beta-yl beta-D-glucoside
3beta,15alpha,16alpha,24alpha-tetrahydroxy25,26,27-trinor-16,24-cyclo-cycloartane-23-one-3-O-beta-D-xylopyranoside
1,1-DIBUTYL-3,3,3,3-TETRAMETHYL-INDADICARBOCYANINE PERCHLORATE
Melongoside A
Constituent of aubergine (Solanum melongena). Melongoside A is found in fruits and eggplant.
2-[[(2R)-3-acetyloxy-2-[8-[3-[(Z)-oct-2-enyl]oxiran-2-yl]octanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[8-[3-[(Z)-oct-2-enyl]oxiran-2-yl]octanoyloxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-3-acetyloxy-2-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(Z)-11-(3-pentyloxiran-2-yl)undec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
sodium globostellatate B
An organic sodium salt that is the monosodium salt of globostellatic acid B. Isolated from the marine sponge Stelletta globostellata, it exhibits cytotoxicity against P-388 murine leukemia cells.
sodium globostellatate C
An organic sodium salt that is the monosodium salt of globostellatic acid C. Isolated from the marine sponge Stelletta globostellata, it exhibits cytotoxicity against P-388 murine leukemia cells.
buxalongifolamidine
A natural product found in Buxus natalensis and Buxus longifolia.
(1S,3R,4S,9R,13S,14R)-13-hydroxy-9-(hydroxymethyl)-3-[(2S,5S)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-2,6,10,17-tetraoxatricyclo[11.3.1.11,5]octadecane-7,11-dione
4-(dimethylamino)-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
4-(dimethylamino)-N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
4-(dimethylamino)-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
4-(dimethylamino)-N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
4-(dimethylamino)-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]butanamide
[(1R,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
2-[[(2R)-3-[(Z)-hexadec-1-enoxy]-2-(5-oxopentanoyloxy)propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2,3-dihydroxypropyl [2-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propyl] hydrogen phosphate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate
[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) icosanoate
(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) docosanoate
(1-Butanoyloxy-3-phosphonooxypropan-2-yl) tricosanoate
(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) octadecanoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate
(1-Acetyloxy-3-phosphonooxypropan-2-yl) pentacosanoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (9Z,12Z)-nonadeca-9,12-dienoate
(1-Phosphonooxy-3-propanoyloxypropan-2-yl) tetracosanoate
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (9Z,12Z)-heptadeca-9,12-dienoate
(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) henicosanoate
[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate
(1-Octanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate
(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) pentadecanoate
(1-Phosphonooxy-3-tridecanoyloxypropan-2-yl) tetradecanoate
(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) hexadecanoate
(1-Decanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] hexadecanoate
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] heptadecanoate
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] hexadecanoate
[1-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-phosphonooxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
[1-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-phosphonooxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
2-[[3-butanoyloxy-2-[(Z)-heptadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-hexanoyloxy-2-[(Z)-pentadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[(Z)-hexadec-9-enoyl]oxy-3-pentanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-acetyloxy-2-[(Z)-nonadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-octanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[3-heptanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[2-[(Z)-octadec-9-enoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
(17z,19z,21z,23z,25z)-4,6,10,12,14,16-hexahydroxy-28-isopropyl-3,15,27-trimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one
(2r,3s,4s,5r,6r)-2-(hydroxymethyl)-6-[(1'r,2r,2's,4's,5s,7's,8'r,9's,12's,13's,16's,18's)-5,7',9',13'-tetramethyl-5'-oxaspiro[oxane-2,6'-pentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosane]oxy]oxane-3,4,5-triol
2-[(2s,4as,8s,8as)-8-{[(2s,3r,4r)-2-(2h-1,3-benzodioxol-5-yl)-4-(2h-1,3-benzodioxol-5-ylmethyl)oxolan-3-yl]methoxy}-4a,8-dimethyl-octahydronaphthalen-2-yl]propan-2-ol
(2s,3r,4s,5r)-2-{[(1s,4r,5r,6r,8r,10s,12s,13s,15s,16r,18s,21r)-8-ethoxy-15-hydroxy-4,6,12,17,17-pentamethyl-9-oxahexacyclo[11.9.0.0¹,²¹.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosan-18-yl]oxy}oxane-3,4,5-triol
4,6,10,12,14,16-hexahydroxy-28-isopropyl-3,15,27-trimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one
3a-hydroxy-9a,11a-dimethyl-1-(5-oxo-2h-furan-3-yl)-7-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-tetradecahydrocyclopenta[a]phenanthren-2-yl acetate
(4ar,5s,6r,8ar)-5-{2-[1-(4-{[(2e)-1-hydroxy-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-ylidene]amino}butyl)-5-oxo-2h-pyrrol-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalene-1-carboxylic acid
(3s,4r,6r,10s,12s,14s,15s,16s,17e,19e,21e,23e,25e,27r,28s)-4,6,10,12,14,16-hexahydroxy-28-isopropyl-3,15,27-trimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one
(1s,2s,3s,4r,5r,6r)-2,3,4,5-tetrahydroxy-6-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}cyclohexyl (9s)-9-methylheptadecanoate
(17e,19e)-21-ethyl-9,11,16-trihydroxy-13-methoxy-10,12,16,18,24-pentamethyl-2,22,26-trioxatricyclo[19.3.1.1⁵,⁸]hexacosa-5,17,19-triene-3,7,23-trione
methyl (1r,2r,4ar,4br,5s,6as,9r,10r,10as,10br,12ar)-5,10-dihydroxy-2-(1-methoxy-2-methyl-1-oxopropan-2-yl)-1-(2-methoxy-2-oxoethyl)-1,4a,4b,9,10-pentamethyl-dodecahydro-2h-chrysene-6a-carboxylate
(1s,3r,4s,5s,9r,13s,14r)-13-hydroxy-9-(hydroxymethyl)-3-[(2s,5s)-5-(3-hydroxyphenyl)-5-methoxypentan-2-yl]-4,14,16,16-tetramethyl-2,6,10,17-tetraoxatricyclo[11.3.1.1¹,⁵]octadecane-7,11-dione
(1ar,2r,3s,3as,5r,6r,7ar,7bs)-2-[(2e)-but-2-en-2-yl]-6-hydroxy-1a,6-dimethyl-3-[(1e,3e)-4-[(4s,5s)-2,2,5-trimethyl-1,3-dioxan-4-yl]penta-1,3-dien-1-yl]-octahydronaphtho[1,2-b]oxiren-5-yl 2-phenylacetate
(25S)-5β-sprostane-3β-ol-3-O-β-D-glucopyranoside
{"Ingredient_id": "HBIN004790","Ingredient_name": "(25S)-5\u03b2-sprostane-3\u03b2-ol-3-O-\u03b2-D-glucopyranoside","Alias": "NA","Ingredient_formula": "C33H54O8","Ingredient_Smile": "CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CCC6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)O)O)C)C)C)OC1","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "38986","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}